Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

Clinical trial NCT02377921 · COMPLETED

Trial details

NCT number: NCT02377921
Sponsor: Ultragenyx Pharmaceutical Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Inclusion Body Myopathy Distal Myopathy With Rimmed Vacuoles Distal Myopathy, Nonaka Type GNE Myopathy

Start date: 2015-05-20
Primary completion: 2017-06-09
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.